Yulius Y. Setiady

1.7k total citations
35 papers, 1.1k citations indexed

About

Yulius Y. Setiady is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yulius Y. Setiady has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yulius Y. Setiady's work include HER2/EGFR in Cancer Research (15 papers), T-cell and B-cell Immunology (11 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Yulius Y. Setiady is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), T-cell and B-cell Immunology (11 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Yulius Y. Setiady collaborates with scholars based in United States, Japan and Indonesia. Yulius Y. Setiady's co-authors include Peter U. Park, Jennifer A. Coccia, Kenneth S. K. Tung, Eileen T. Samy, Masami Sekine, Hiroshi Kouchi, Norimitsu Hariguchi, Patcharin Pramoonjago, Colin Sharp and Ravi Chari and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Yulius Y. Setiady

33 papers receiving 1.1k citations

Peers

Countries citing papers authored by Yulius Y. Setiady

Since Specialization

Citations

This map shows the geographic impact of Yulius Y. Setiady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulius Y. Setiady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulius Y. Setiady more than expected).

Fields of papers citing papers by Yulius Y. Setiady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulius Y. Setiady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulius Y. Setiady. The network helps show where Yulius Y. Setiady may publish in the future.

Co-authorship network of co-authors of Yulius Y. Setiady

This figure shows the co-authorship network connecting the top 25 collaborators of Yulius Y. Setiady. A scholar is included among the top collaborators of Yulius Y. Setiady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulius Y. Setiady. Yulius Y. Setiady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characteristics of hepatitis B virus surface protein and occult hepatitis B infection in infants with immunoprophylaxis failure from Indonesia 2025 ·Vaccine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yulius Y. Setiady, David Handojo Muljono	0
2	Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy 2020 ·Molecular Cancer Therapeutics ·Jose F. Ponte, Leanne Lanieri, Eshita Khera, Rassol Laleau, Olga Ab, Christopher W. Espelin, Neeraj Kohli, (unknown), Yulius Y. Setiady, Michael L. Miller, Thomas A. Keating, Ravi Chari, Jan Pinkas, Richard J. Gregory, Greg M. Thurber	29
3	Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody–Drug Conjugates (ADCs) 2019 ·ACS Medicinal Chemistry Letters ·Katie E. Archer, (unknown), (unknown), James R. Woods, Luke Harris, Erin K. Maloney, Laura M. Bartle, Olga Ab, Alan Wilhelm, Yulius Y. Setiady, Jose F. Ponte, Rajeeva Singh, Thomas A. Keating, Ravi Chari, Michael L. Miller	9
4	A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells 2018 ·Blood Advances ·Yelena Kovtun, Gregory E. Jones, Sharlene Adams, Lauren Harvey, Charlene A. Audette, Alan Wilhelm, Chen Bai, Lingyun Rui, Rassol Laleau, (unknown), Olga Ab, Yulius Y. Setiady, Nicholas C. Yoder, Victor S. Goldmacher, Ravi Chari, Jan Pinkas, Thomas Chittenden	129
5	ErbB3–ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas 2015 ·Cancer Research ·Claudia Capparelli, Sheera R. Rosenbaum, Lisa D. Berman-Booty, (unknown), Nadège Gaborit, Tingting Zhan, Inna Chervoneva, Jason Roszik, Scott E. Woodman, Michael A. Davies, Yulius Y. Setiady, Iman Osman, Yosef Yarden, Andrew E. Aplin	18
6	Function-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF Inhibitor 2014 ·Cancer Research ·Curtis H. Kugel, Edward J. Hartsough, Michael A. Davies, Yulius Y. Setiady, Andrew E. Aplin	45
7	Abstract 4513: IMGN289, an EGFR-targeting antibody-drug conjugate, is effective against tumor cells that are resistant to EGFR tyrosine kinase inhibitors 2014 ·Cancer Research ·Yulius Y. Setiady, Ling Dong, Anna Skaletskaya, Jan Pinkas, Robert J. Lutz, John M. Lambert, Thomas Chittenden	3
8	In vivo depletion of CD4⁺FOXP3⁺ Treg cells by the PC61 anti‐CD25 monoclonal antibody is mediated by FcγRIII⁺ phagocytes 2009 ·European Journal of Immunology ·Yulius Y. Setiady, Jennifer A. Coccia, Peter U. Park	187
9	The role of physiological self‐antigen in the acquisition and maintenance of regulatory T‐cell function 2006 ·Immunological Reviews ·Eileen T. Samy, Yulius Y. Setiady, (unknown), Patcharin Pramoonjago, Colin Sharp, Kenneth S. K. Tung	54
10	Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+CD25+ regulatory T cells 2005 ·Blood ·Yulius Y. Setiady, (unknown), Eileen T. Samy, Harini Bagavant, Hui Qiao, Colin Sharp, Jin‐Xiong She, Kenneth S. K. Tung	46
11	Neonatal Autoimmune Disease: Influence of CD4⁺CD25⁺Regulatory T Cells 2005 ·International Reviews of Immunology ·Yulius Y. Setiady, Sally Agersborg, Eileen T. Samy, Janet E. Lewis, Kenneth S. K. Tung	7
12	Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720 2005 ·Journal of Biological Chemistry ·Yugesh Kharel, Sangderk Lee, Ashley H. Snyder, (unknown), Margaret A. Morris, Yulius Y. Setiady, Ran Zhu, (unknown), Tracy L. Burcin, Klaus Ley, Kenneth S. K. Tung, Víctor H. Engelhard, Timothy L. Macdonald, Sonia Pearson‐White, Kevin R. Lynch	178
13	Autoimmune Ovarian Disease in Day 3-Thymectomized Mice: The Neonatal Time Window, Antigen Specificity of Disease Suppression, and Genetic Control 2005 ·Current topics in microbiology and immunology ·(unknown), Yulius Y. Setiady, Eileen T. Samy, Jacob S. Lewis, Cory Teuscher	20
14	Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex 2004 ·The Journal of Immunology ·Yulius Y. Setiady, Patcharin Pramoonjago, Kenneth S. K. Tung	19
15	Maternal Autoantibody Triggers De Novo T Cell-Mediated Neonatal Autoimmune Disease 2003 ·The Journal of Immunology ·Yulius Y. Setiady, Eileen T. Samy, Kenneth S. K. Tung	36
16	Endogenous Oocyte Antigens Are Required for Rapid Induction and Progression of Autoimmune Ovarian Disease Following Day-3 Thymectomy 2001 ·The Journal of Immunology ·Pascale Alard, Claire Thompson, Sally Agersborg, Jayant Thatte, Yulius Y. Setiady, Eileen T. Samy, Kenneth S. K. Tung	34
17	Expression library immunization protects mice against a challenge with virulent rodent malaria 2000 ·Vaccine ·Peter M. Smooker, Yulius Y. Setiady, Adam Rainczuk, Terry W. Spithill	29
18	Expression pattern of tobacco cyclin genes 1997 ·Plant Cell Reports ·Yulius Y. Setiady, Masami Sekine, Takahiro Yamamoto, Hiroshi Kouchi, Atsuhiko Shinmyō	3
19	Molecular Cloning and Characterization of a cDNA Clone That Encodes a Cdc2 Homolog from Nicotiana tabacum 1996 ·Plant and Cell Physiology ·Yulius Y. Setiady, Masami Sekine, Norimitsu Hariguchi, Hiroshi Kouchi, (unknown)	29
20	Tobacco mitotic cyclins: cloning, characterization, gene expression and functional assay 1995 ·The Plant Journal ·Yulius Y. Setiady, Masami Sekine, Norimitsu Hariguchi, Takuo Yamamoto, Hiroshi Kouchi, Atsuhiko Shinmyō	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact